Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

AIMS: Dual antiplatelet therapy reduces non-fatal ischaemic events after acute coronary syndrome (ACS) but increases bleeding to a similar extent. We sought to determine the prognostic impact of myocardial infarction (MI) vs. bleeding during an extended follow-up period to gain insight into the trad...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur Heart J
Main Authors: Valgimigli, Marco, Costa, Francesco, Lokhnygina, Yuliya, Clare, Robert M., Wallentin, Lars, Moliterno, David J., Armstrong, Paul W., White, Harvey D., Held, Claes, Aylward, Philip E., Van de Werf, Frans, Harrington, Robert A., Mahaffey, Kenneth W., Tricoci, Pierluigi
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Clinical Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5837470/
https://ncbi.nlm.nih.gov/pubmed/28363222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehw525
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares